Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Human Factors

Date Submitted: Oct 2, 2020
Date Accepted: Dec 29, 2021

The final, peer-reviewed published version of this preprint can be found here:

Acceptance of the Use of Artificial Intelligence in Medicine Among Japan’s Doctors and the Public: A Questionnaire Survey

Tamori H, Yamashina H, Mukai M, Morii Y, Suzuki T, Ogasawara K

Acceptance of the Use of Artificial Intelligence in Medicine Among Japan’s Doctors and the Public: A Questionnaire Survey

JMIR Hum Factors 2022;9(1):e24680

DOI: 10.2196/24680

PMID: 35293878

PMCID: 8968553

Acceptance of the Use of Artificial Intelligence in Medicine Among Japan’s Doctors and the Public: Questionnaire Survey

  • Honoka Tamori; 
  • Hiroko Yamashina; 
  • Masami Mukai; 
  • Yasuhiro Morii; 
  • Teppei Suzuki; 
  • Katsuhiko Ogasawara

ABSTRACT

Background:

The use of artificial intelligence (AI) in the medical industry promises many benefits so AI has been introduced to medicine primarily in developed countries. In Japan, the government is preparing for the rollout of AI in the medical industry. This rollout depends on doctors and the public accepting the technology. It is therefore necessary to consider acceptance among doctors and among the public. However, little is known about the acceptance of AI in medicine.

Objective:

This study aimed to obtain detailed data on acceptance of AI in medicine by comparing the acceptance among Japanese doctors with that among the Japanese public.

Methods:

We conducted an online survey, and the responses of doctors and members of the public were compared. A questionnaire was prepared referred to the Unified Theory of Acceptance and Use of Technology, a model of behavior toward new technologies. It comprises 20 items, and each item was rated on a five-point scale. Using this questionnaire, we conducted an online survey in 2018 among 399 doctors and 600 members of the public. The sample-wide responses were analyzed, and then the responses of the doctors were compared with those of the public using a Wilcoxon rank sum test.

Results:

Regarding the sample-wide responses (N=999), 653 (65.4%) of the respondents believed that AI would be necessary in medicine in the future, whereas only 447 (44.7%) expressed an intention to use AI-driven medicine. Additionally, 730 (73.1%) believed that regulatory legislation was necessary, and 734 (73.5%) were concerned about where accountability lies. Regarding the comparison between doctors and the public, doctors (median; 4, mean; 3.43) were more likely than members of the public(median; 3, mean; 3.23) to express intention to use AI-driven medicine (P<.001), suggesting that optimism about AI in medicine is greater among doctors compared with the public.

Conclusions:

Many of the respondents were optimistic with the role of AI in medicine. However, when asked whether they would like to use AI-driven medicine, they tended to give a negative response. This trend suggests that concerns about the lack of regulation and about accountability hindered acceptance. Additionally, the results revealed that doctors were more enthusiastic than members of the public regarding AI-driven medicine.


 Citation

Please cite as:

Tamori H, Yamashina H, Mukai M, Morii Y, Suzuki T, Ogasawara K

Acceptance of the Use of Artificial Intelligence in Medicine Among Japan’s Doctors and the Public: A Questionnaire Survey

JMIR Hum Factors 2022;9(1):e24680

DOI: 10.2196/24680

PMID: 35293878

PMCID: 8968553

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.